PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
50 hedge funds and large institutions have $60M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 12 closing their positions.
Holders
50
Holders Change
-10
Holders Change %
-16.67%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
18
Reduced
15
Closed
12
Calls
$61K
Puts
–
Net Calls
+$61K
Net Calls Change
+$51K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Renaissance Technologies
New York
| – | -$605K | -131,500 | Closed |
|
52
Ameriprise
Minneapolis,
Minnesota
| – | -$406K | -88,346 | Closed |
|
|
BBP
53
Banco BTG Pactual
Rio De Janeiro,
Brazil
| – | -$154K | -33,500 | Closed |
|
54
TD Asset Management
Toronto,
Ontario, Canada
| – | -$149K | -32,443 | Closed |
|
|
SAMH
55
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
| – | -$140K | -30,500 | Closed |
|
56
First Trust Advisors
Wheaton,
Illinois
| – | -$138K | -30,008 | Closed |
|
|
PPA
57
Parametric Portfolio Associates
Seattle,
Washington
| – | -$92K | -20,066 | Closed |
|
|
FC
58
FORA Capital
Miami,
Florida
| – | -$58K | -12,556 | Closed |
|
59
RhumbLine Advisers
Boston,
Massachusetts
| – | -$55K | -11,932 | Closed |
|
60
UBS Group
Zurich,
Switzerland
| – | -$37K | -8,121 | Closed |
|
61
Simplex Trading
Chicago,
Illinois
| – | -$13K | -2,839 | Closed |
|